BACKGROUND
The effect of transcatheter tricuspid-valve repair on clinical outcomes, including death and hospitalization for heart failure, in patients with severe tricuspid regurgitation remains uncertain.
METHODS
We randomly assigned patients with symptomatic severe tricuspid regurgitation and an increased risk of f...
J. Hausleiter, T. Stocker, Tobias Geisler et al.· New England Journal of Medic...· 8 citations· ⚡1
Treatment with a potent P2Y12 inhibitor was associated with higher bleeding rates without a clear reduction in the risk of ischemic complications, and these findings do not support the routine use of potent P2Y12 inhibitors in combination with DOACs in this patient population.
Konstantinos D. Rizas, K. Mourouzis, D. Rath et al.· Nature Medicine· 3 citations
One-year MiCLASP results support the safety of mitral transcatheter edge-to-edge repair with the PASCAL system in both AFMR and VFMR, with comparable echocardiographic, functional, and quality-of-life changes, despite baseline differences in clinical presentation.
A. Mahabadi, T. Rassaf, T. Kister et al.· Circulation. Cardiovascular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.